Safety, pharmacokinetic and pharmacodynamic study in healthy subjects of oral neo6860, A modality selective TRPV1 antagonist

Company Name

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum porta libero erat. Nullam at ipsum quis felis egestas vulputate nec nec ligula.

February 8, 2017

The Journal of Pain